Livermore S, Piskuric NA, Buttigieg J, Zhang M, Nurse CA. Low glucose sensitivity and polymodal chemosensing in neonatal rat adrenomedullary chromaffin cells. Am J Physiol Cell Physiol 301: C1104 -C1115, 2011. First published July 20, 2011 doi:10.1152/ajpcell.00170.2011Glucose is the primary metabolic fuel in mammalian fetuses, yet mammals are incapable of endogenous glucose production until several hours after birth. Thus, when the maternal supply of glucose ceases at birth there is a transient hypoglycemia that elicits a counterregulatory surge in circulating catecholamines. Because the innervation of adrenomedullary chromaffin cells (AMCs) is immature at birth, we hypothesized that neonatal AMCs act as direct glucosensors, a property that could complement their previously established roles as hypoxia and acid hypercapnia sensors. During perforated-patch, whole cell recordings, low glucose depolarized and/or excited a subpopulation of neonatal AMCs; in addition, aglycemia (0 mM glucose) caused inhibition of outward K ϩ current, blunted by the simultaneous activation of glibenclamidesensitive K ATP channels. Some cells were excited by each of the three metabolic stimuli, i.e., aglycemia, hypoxia (PO2 ϳ30 mmHg), and isohydric hypercapnia (10% CO2; pH ϭ 7.4). Using carbon fiber amperometry, aglycemia and hypoglycemia (3 mM glucose) induced robust catecholamine secretion that was sensitive to nickel (50 M and 2 mM) and the L-type Ca 2ϩ channel blocker nifedipine (10 M), suggesting involvement of both T-type and L-type voltage-gated Ca 2ϩ channels. Fura-2 measurements of intracellular Ca 2ϩ ([Ca 2ϩ ]i) revealed that ϳ42% of neonatal AMCs responded to aglycemia with a significant rise in [Ca 2ϩ ]i. Approximately 40% of these cells responded to hypoxia, whereas ϳ25% cells responded to both aglycemia and hypoxia. These data suggest that together with hypoxia and acid hypercapnia, low glucose is another important metabolic stimulus that contributes to the vital asphyxia-induced catecholamine surge from AMCs at birth. aglycemia; hypoglycemia; hypoxia; catecholamines; K ϩ current ALTHOUGH GLUCOSE IS THE PRIMARY metabolic fuel in the fetus, glycogenolysis and gluconeogenesis are absent in utero (27). As a result, fetuses are completely dependent on their mothers for the transplacental facilitated diffusion of glucose. During normal birth, this transport ceases, leading to a decrease in blood glucose (hypoglycemia) in the first few hours of life (26, 30, 39, 51, 54) . In the newborn, hypoglycemia activates a counterregulatory surge in catecholamines and glucagon and a fall in insulin (11). These hormonal changes stabilize blood glucose by initiating glycogenolysis in liver hepatocytes (21, 29) . Despite this response, over 2% of newborns experience hypoglycemia and require clinical intervention (13), increasing the risk of brain damage (36). Moreover, premature infants, newborns of diabetic mothers, and neonates small-for-gestational age are at increased risk of hypoglycemia, which is one of the primary causes of increased neonatal mortality and morbidity among these individuals (61). In adult mammals, hypoglycemia acts via hypothalamic neurons to initiate the neurogenic release of catecholamines from adrenomedullary chromaffin cells (AMCs), and on pancreatic ␣-and ␤-cells to evoke glucagon secretion and inhibit insulin release. However, pancreatic ␣-cells are glucose insensitive until several weeks after birth (14, 34, 38, 49) , and splanchnic innervation of the adrenal gland is immature in most neonatal mammals (including rats and humans) (1, 60). In newborn rats, adrenalectomy or infusion with adrenergic antagonists prevents hepatic glycogen breakdown and causes severe hypoglycemia (20) . These data suggest that counterregulatory changes in response to hypoglycemia require adrenal catecholamine secretion via an unknown nonneurogenic mechanism in the newborn. Indeed, other metabolic factors including low O 2 (hypoxia) and high CO 2 /H ϩ (acid hypercapnia), associated with fetal asphyxia during birth and neonatal apnoeic episodes, have been shown to stimulate catecholamine secretion from neonatal AMCs via direct, nonneurogenic mechanisms (4, 31, 40, 41, 48, 56, 58) . For example, hypoxia causes inhibition of a variety of K ϩ channels in these cells, leading to membrane depolarization, voltage-gated Ca 2ϩ entry, and catecholamine secretion (40, 41, 58) .
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In the present study, we hypothesized that neonatal AMCs may also directly sense hypoglycemia and initiate catecholamine secretion, similar to their sympathoadrenal counterparts in the carotid body, i.e., type I cells, which have recently been shown to act as direct glucosensors (18, 42, 63) . Moreover, recent studies from this laboratory demonstrated that aglycemia produced membrane depolarization and a rise in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in immortalized AMCs derived from E14 fetal rat adrenal medulla (44) . Here, we use short-term cultures of primary dissociated rat AMCs combined with patch-clamp electrophysiology, carbon fiber amperometry, and ratiometric [Ca 2ϩ ] i imaging to show that at least a subpopulation of these cells is sensitive to low glucose. We also show that among the aglycemia-sensitive subpopulation are cells that are sensitive to hypoxia and/or hypercapnia, consistent with the idea that at least some neonatal AMCs act as polymodal chemosensors.
MATERIALS AND METHODS
Animal procedures. Pregnant Wistar rats (Charles River, Quebec, Canada) were delivered to our animal care facility and gave birth naturally 2 wk later. They were given ad libitum access to food and water and kept under a 12:12-h light-dark cycle at 22°C. Newborn rats (0 -2 days old) were rendered unconscious by a blow to the back of the head and then killed by decapitation before removal of the adrenal glands. All procedures for animal handling and experimentation were approved by the McMaster University Animal Research and Ethics Board, in accordance with the guidelines of the Canadian Council for Animal Care.
Cell culture. Preparation of cultures of dissociated rat AMCs was carried out as previously described (58) . Briefly, adrenal glands were removed from postnatal day 0 (P0) rats and most of the surrounding cortical tissue was removed and discarded. The remaining medullary regions were incubated for 1 h at 37°C in an enzymatic solution containing 0.1% trypsin (Gibco), 0.1% collagenase (Gibco), and 0.01% deoxyribonuclease (Millipore). Following digestion, the enzymatic solution was removed and replaced with a modified F-12 medium. The medullary tissue was then mechanically dissociated using forceps and triturated with a Pasteur pipette, and the dispersed cells were pelleted by centrifugation. Cells were then plated on culture dishes coated with Matrigel (Collaborative Research) and grown at 37°C in an incubator with a humidified atmosphere of 95% air-5% CO 2 for 1-2 days before experiments were performed. The growth medium consisted of F-12 medium (Invitrogen), supplemented with 10% fetal bovine serum and other additives as described previously (58) .
Electrophysiology. Nystatin perforated-patch whole cell recording was used as previously described (63) . Briefly, membrane potential and voltage-activated currents were measured in single AMCs with the aid of an Axopatch 1D amplifier, a Digidata 1200 A-D converter, connected to a headstage (Molecular Devices). Data were stored on a personal computer and analyzed with pCLAMP software (version 9.0, Molecular Devices). Cells were perfused with a standard bicarbonatebuffered saline (BBS, see below) bubbled with 95% air-5% CO 2 at 37°C. The pipette solution contained 115 mM K-gluconate, 25 mM KCl, 5 mM NaCl, 1 mM CaCl2, 10 mM HEPES, and 300 g/ml nystatin, at pH 7.2.
Carbon fiber amperometry. Cell cultures were placed on the stage of an inverted microscope (Accu-Scope 3030) and perfused under gravity with a HEPES-buffered recording solution at pH 7.4 (see below). Catecholamine secretion was monitored by placing a ProCFE carbon fiber electrode (Dagan) in close apposition to the plasma membrane of an AMC. The electrodes were connected to a CV 203BU headstage and an Axopatch 200B amplifier set at ϩ800 mV. Data were filtered at 100 Hz and digitized at 250 Hz using Clampex 9.2 (Axon Instruments) and subsequently analyzed with Clampfit 9.2 (Axon Instruments). Individual secretory events were rejected if they were below 2.58 times the standard deviation (99% confidence interval) of the baseline noise (typically 1-3 pA) and did not have an exponential decay. The quantal charge was measured as the integrated area under each spike, and the mean quantal charge per cell was calculated according to the method previously described (9) . Q 1/3 was calculated by taking the cube root of the quantal charge, which is proportional to vesicular radius (15) . Frequency was calculated as the number of single quantal events per minute, and secretion rate was measured as the cumulative charge resulting from the sum of successive single quantal events over a given time interval. AMCs were considered glucosensitive if there was a greater than twofold increase in secretion rate when cells were exposed to aglycemia (i.e., 0 mM glucose) compared with control (5 mM glucose). Furthermore, only healthy cells, i.e., those that responded to high K ϩ (30 mM KCl) with robust catecholamine secretion, were analyzed for responses to low glucose.
Fura-2 spectrofluorimetry. Intracellular Ca 2ϩ concentrations ([Ca 2ϩ ]i) were measured as previously described (44) . Briefly, neonatal AMCs were loaded with 2.5 M Fura-2 for 10 -15 min at room temperature in HEPES-buffered saline and then rinsed for 10 min with BBS. Cells were placed on the stage of a Nikon Eclipse TE2000-U inverted microscope, and fluorescence measurements were obtained with the aid of a Lambda DG-4 ultra high-speed wavelength changer (Sutter Instrument, Novato, CA). During data collection, cells were perfused by a peristaltic pump with a BBS (see below) bubbled with 5% Solutions. The standard BBS solution contained (in mM) 24 NaHCO 3, 115 NaCl, 0 -10 glucose, 22-12 sucrose, 5 KCl, 2 CaCl2, and 1 MgCl2, at 37°C, and the pH was kept at 7.4 by bubbling the solution with a 95% air-5% CO2 gas mixture. HEPES-buffered saline contained (in mM) 135 NaCl, 10 HEPES, 0 -10 glucose, 10 -0 sucrose, 5 KCl, 2 CaCl2, and 2 MgCl2, at pH ϭ 7.4. The concentration of glucose ranged from 10 mM to 0 mM, and osmolarity was kept constant by equimolar substitution with sucrose. For experiments done with isohydric hypercapnia, the NaHCO 3 concentration was raised to 48 mM with an equimolar substitution of NaCl and bubbled with 10% CO2-90% air. Solutions were made hypoxic (PO2 ϳ30 mmHg) by bubbling HEPES-buffered saline with 100% N2 gas or BBS with a 95% N2-5% CO2 gas mixture. High-K ϩ (30 mM) solutions were kept at constant osmolarity by equimolar substitution with NaCl. Glibenclamide, nickel, and nifedipine were purchased from Sigma.
Statistical analysis. Results are expressed as means Ϯ SE. Comparisons were done with Student's t-tests or ANOVA where appropriate.
RESULTS
Effects of hypoglycemia on membrane potential and action potential frequency in neonatal chromaffin cells. Using perforated-patch whole cell recording, we first monitored the effects of hypoglycemia on membrane potential and/or voltage-activated outward K ϩ currents in neonatal AMCs cultured for 1-2 days. When cells were exposed to 10 mM glucose, spontaneous action potentials were usually absent (Fig. 1A) . However, as exemplified in Figs. 1A and 3A2, exposure to aglycemia (0 mM glucose) resulted in membrane depolarization sometimes leading to action potentials in a subpopulation of cells, and the effect was reversible. In this series, ϳ35% of neonatal AMCs (n ϭ 13/37) depolarized in response to aglycemia; the mean aglycemia-induced depolarization in responsive cells was 3.8 Ϯ 0.6 mV (n ϭ 13). In cells that elicited action potentials during aglycemia, spike frequency increased from ϳ0 Hz in 10 mM glucose to a maximum of 0.8 Ϯ 0.2 Hz during aglycemia (P Ͻ 0.001, n ϭ 8 cells). In these cells the effect of glucose was dose dependent as illustrated in Fig. 1, A (18, 42) , we investigated whether a similar mechanism operates in neonatal AMCs. As shown in the exemplar trace ( Fig. 2A) and current density vs. voltage (I-V) plot (Fig. 2C) , aglycemia inhibited the outward K ϩ current at more positive membrane potentials; for a voltage step to ϩ30 mV, there was ϳ40% inhibition of outward current during aglycemia (n ϭ 6).
Opening of ATP-sensitive K ϩ (K ATP ) channels reduces the magnitude of outward K ϩ current inhibition during acute hypoxia in primary neonatal rat AMCs (4, 59) , as well as the rise in [Ca 2ϩ ] i induced by aglycemia in fetal-derived, immortalized rat AMCs (44) . We therefore tested whether a similar opening of K ATP channels reduces the inhibition of outward K ϩ current in primary neonatal AMCs exposed to aglycemia. Indeed, addition of the K ATP channel blocker glibenclamide (50 M) enhanced the aglycemia-induced inhibition of outward K ϩ current seen at more positive potentials (Fig. 2, B1 , B2, and C; n ϭ 6). Furthermore, under current clamp, the addition of glibenclamide (50 M) potentiated the effects of aglycemia (n ϭ 6), as exemplified for a glucose-sensitive AMC ( Fig. 2D ) and for an AMC that initially would have been considered glucose-insensitive (Fig. 2E) ; in both cases the increased membrane depolarization was sufficient to trigger action potential firing when glibenclamide was present. Previous studies in this laboratory have demonstrated that glibenclamide alone had negligible effect on resting membrane potential and ionic currents in neonatal AMCs under normoxic conditions (6, 59) . These data suggest that aglycemia activates K ATP channels in these cells favoring membrane hyperpolarization, and this occurs in parallel with the inhibition of other voltage-dependent K ϩ channels and/or activation of channels that promote membrane depolarization.
Electrophysiological evidence for polymodal chemosensing in aglycemia-sensitive chromaffin cells. Because some neonatal AMCs are sensitive to both hypercapnia and hypoxia (7), we wondered whether the same cell could respond to aglycemia as well as hypoxia and/or hypercapnia. As exemplified by current-clamp recordings shown in Fig. 3 , A1-A3, hypoxia, aglycemia, and isohydric hypercapnia (10% CO 2 ; pH ϭ 7.4) could separately excite the same cell, with each stimulus producing a burst of action potentials or, in some cases, membrane depolarization. Furthermore, under voltage clamp, all three stimuli caused a significant inhibition of outward K ϩ current in the same cell, as shown in the exemplar traces of Fig.  3 , B1-B3. In one experimental series a total of 41 cells were exposed sequentially to hypoxia, aglycemia, and hypercapnia, separated by a return to control solution before the next stimulus was applied. It was found that ϳ27% (11/41) of these cells were sensitive to all three stimuli, ϳ27% (11/41) were sensitive to both aglycemia and hypercapnia, ϳ5% (2/41) were sensitive to aglycemia only, and the remaining ϳ41% (17/41) failed to respond to any of the three stimuli. Pooled data from several experimental series comparing the effects of hypoxia and aglycemia on percent inhibition of outward K ϩ current are summarized in Fig. 3 , C and D, respectively, for voltage steps to ϩ30 mV, where hypoxia reduced outward K ϩ current by ϳ25% from 487.0 Ϯ 23.1 pA to 365.7 Ϯ 20.7 pA (n ϭ 35; P Ͻ 0.001), and aglycemia reduced this current by ϳ59% from 434.3 Ϯ 15.6 pA to 179.6 Ϯ 8.3 pA (n ϭ 86; P Ͻ 0.001). For comparison, isohydric hypercapnia (10% CO 2 ; pH ϭ 7.4) reduced the outward current by ϳ62%, from 463.3 Ϯ 13.8 pA to 176.6 Ϯ 9.6 pA (n ϭ 79; P Ͻ 0.001). Furthermore, under current clamp, isohydric hypercapnia depolarized the membrane potential by 6.5 Ϯ 0.9 mV (n ϭ 35) and increased the action potential firing in quiescent cells from ϳ0 Hz to 0.8 Ϯ 0.1 Hz (n ϭ 31).
Because there is a positive interaction between hypoxia and hypoglycemia in related carotid body type I cells (18), we tested the effects of glucose concentration on the inhibition of the outward K ϩ current at varying PO 2 . In general, the K ϩ current inhibition at a given PO 2 was enhanced as the glucose concentration was lowered (Fig. 3E) . Also during aglycemia, the inhibition of outward K ϩ current during a step depolarization to ϩ30 mV (from Ϫ60 mV holding potential) increased from 33.6 Ϯ 1.5% at a PO 2 of 120 mmHg to 63.1 Ϯ 1.7% at a PO 2 of 20 mmHg ( Fig. 3E ; n ϭ 6). These data indicate that, in neonatal AMCs, mild or severe hypoxia could potentiate the effects of low glucose on K ϩ current inhibition and vice versa. Low glucose induces catecholamine secretion from neonatal AMCs. Given the above electrophysiological evidence for the presence of a low-glucose sensing mechanism in neonatal AMCs, we next investigated whether low glucose could stimulate catecholamine secretion from these cells using carbon fiber amperometry. When the perfusion fluid was switched from one containing 5 mM glucose to another with 0 mM glucose (aglycemia), there was a robust secretory response from ϳ34% (17/50) neonatal AMCs (Fig. 4A, middle) . The reversible bursts of spikelike activity were qualitatively similar to the secretory responses evoked by hypoxia and hypercapnia in previous studies on neonatal AMCs (17, 41) . The fast rise time and slow exponential decay of these amperometric spikes are characteristic of vesicular release (Fig. 4A, bottom trace) , and the increase in cumulative charge during aglycemia reflects a robust catecholamine secretory response induced by this stimulus (Fig. 4A, top) .
The increased catecholamine secretion during aglycemia could be attributable to an increase in frequency of exocytotic events, mean quantal charge, or both. In neonatal AMCs, aglycemia increased the frequency of quantal events ϳ3.4-fold ( Fig. 4B ; P Ͻ 0.001, n ϭ 17 cells) and increased the mean quantal charge ϳ2.7-fold ( Fig. 4C ; P Ͻ 0.001, n ϭ 17 cells). Aglycemia-and high K ϩ -evoked quantal events were right skewed and followed a similar distribution. However, Q 1/3 , a measure of vesicular radius, was best fit with a single Gaussian ϩ current is potentiated when the same cell, illustrated in B1, is subsequently exposed to aglycemia plus the KATP channel blocker glibenclamide (50 M; Glib) as illustrated in B2. C: current density (in pA/pF) vs. voltage plots showing inhibition of outward K ϩ current at positive potentials by aglycemia (0 Gluc) and the increased inhibition when the KATP channel blocker glibenclamide was present; label "c" refers to initial control response, and "w" refers to responses after drug washout. At voltages above ϩ10 mV, glibenclamide produced a statistically significant increase in the aglycemia-mediated inhibition of the outward K ϩ current density (P Ͻ 0.001; ANOVA, n ϭ 6). D: exemplar trace from a glucose-sensitive cell (left) in which glibenclamide (50 M) augmented membrane depolarization and produced action potential firing (right). E: exemplar trace from a glucose-insensitive cell (left) in which glibenclamide (50 M) induced membrane depolarization and action potential firing (right). Dashed lines indicate resting membrane potential. Data points indicate meanϮ SE; n ϭ 6. distribution that was similar for both aglycemia (mean ϭ 2.42 Ϯ 0.07 fC 1/3 ; n ϭ 17) and high K ϩ (mean ϭ 2.55 Ϯ 0.07 fC 1/3 ; n ϭ 17), consistent with release from a common vesicular pool. Q 1/3 increased ϳ1.4-fold in 0 mM glucose compared with 5 mM glucose (P Ͻ 0.001, n ϭ 17 cells). In responsive cells, the secretion rate, estimated from the product of mean quantal charge and event frequency, increased ϳ8-fold from 98.6 Ϯ 31.6 fC/min during 5 mM glucose to 789.8 Ϯ 236.5 fC/min during aglycemia ( Fig. 4D ; P Ͻ 0.01, n ϭ 17 cells).
Some cells showed no secretory response to aglycemia, but otherwise appeared healthy based on the presence of a robust high K ϩ -evoked secretion (Fig. 4E) . In these cells, exposure to 0 mM glucose did not cause any significant change in either the frequency of quantal events (P Ͼ 0.30, n ϭ 33 cells) or the quantal charge (P Ͼ 0.96, n ϭ 33 cells); for this group, the basal secretion rate was 74.3 Ϯ 14.6 fC/min in normal glucose (5 mM) compared with 73.8 Ϯ 10.7 fC/min in 0 mM glucose (P Ͼ 0.88, n ϭ 33 cells). Thus, the glucose-insensitive neonatal AMCs analyzed in this study appeared to have intact mechanisms for stimulus-secretion coupling, but could have been missing a vital component required for glucosensing. Similarly, distinct populations of hypoxia-sensitive and hypoxiainsensitive AMCs have been reported in neonatal thin adrenal slices (17) . In the present study, cells that failed to respond to high K ϩ but otherwise appeared normal when viewed under phase contrast microscopy were excluded from further analysis.
Because aglycemia would more commonly occur during pathological situations, it was of interest to test whether neonatal AMCs could mount a detectable secretory response at intermediate glucose concentrations. In these experiments, the perfusion fluid was switched sequentially from 5 mM glucose (control) to 3 mM glucose (hypoglycemia), and finally to 0 Fig. 3 . Neonatal adrenomedullary chromaffin cells are polymodal chemosensors. A: representative traces of current-clamp recordings of a single neonatal chromaffin cell that showed an increase in spike frequency in response to hypoxia (Hox; A1), aglycemia (A2), and isohydric hypercapnia, i.e., 10% CO2; pH ϭ7.4 (A3). B: under voltage clamp, the same cell responded to hypoxia (B1), aglycemia (B2), and isohydric hypercapnia (B3) with inhibition of outward K ϩ current as shown for a voltage step to ϩ30 mV; holding potential ϭ Ϫ60 mV. C: hypoxia causes a significant inhibition of the outward K ϩ current at ϩ30 mV (Student's t-test; ***P Ͻ 0.001, n ϭ 35). D: similarly as in C, the outward K ϩ current at ϩ30 mV was significantly inhibited by aglycemia (Student's t-test; ***P Ͻ 0.001, n ϭ 86). E: plot of percent inhibition of the outward K ϩ current at different glucose concentrations (x-axis), and at varying PO2 indicated by symbols (inset; n ϭ 6). mM glucose (aglycemia), while continuously monitoring catecholamine secretion from the same cell. As exemplified in Fig. 5A , bottom, a secretory response was evident when some neonatal AMCs were exposed to 3 mM glucose (hypoglycemia) (P Ͻ 0.05, n ϭ 7 cells). Although there was a trend toward a lower secretion rate in 3 mM glucose compared with aglycemia, the effect was not statistically significant within this sample ( Fig. 5B ; P Ͼ 0.05, n ϭ 7 cells).
Voltage-gated Ca 2ϩ entry is required for aglycemia-evoked catecholamine release. Hypoxia-, acid-, and hypercapniaevoked catecholamine secretion from neonatal AMCs requires entry of extracellular Ca 2ϩ through voltage-gated Ca 2ϩ channels (VGCCs) ( 40, 41, 46, 58) . Likewise, in the present study (Fig. 6, A and B) , the aglycemia-evoked secretory response was reversibly abolished by extracellular application of the general VGCC blocker Ni 2ϩ (2 mM; P Ͻ 0.05, n ϭ 7 cells). In these experiments, the response to aglycemia appeared stronger after washout of 2 mM Ni 2ϩ ; the mean aglycemia-evoked secretion rate was 1,993 Ϯ 873.1 fC/min (n ϭ 7) after Ni 2ϩ exposure compared with 773.4 Ϯ 305.9 fC/min (n ϭ 7) before the exposure. This apparent enhancement was not attributable to an effect of Ni 2ϩ per se because it was routinely observed during repeated exposures to aglycemia, even in the absence of Ni 2ϩ (data not shown).
To investigate the potential role of L-type VGCCs in the secretory response, the L-type channel blocker nifedipine (10 Fig. 4 . Aglycemia-evoked catecholamine release from neonatal adrenomedullary chromaffin cells. A, top: cumulative charge of catecholamine release corresponding to the cell below. Middle: example of a robust secretory response in a single cell in response to aglycemia. The cell was exposed sequentially to control solution (5 mM glucose), aglycemia (0 mM glucose), and high K ϩ (30 mM KCl) during the period indicated by top horizontal bars. Bottom: expanded time scale trace of amperometric (current) spikes indicative of vesicular release during aglycemia at the indicated time. B: aglycemia increased the frequency of single quantal events compared with normoglycemia (5 mM glucose) (Student's t-test, ***P Ͻ 0.001, n ϭ 17 cells). C: quantal charge increased during aglycemia (Student's t-test, ***P Ͻ 0.001, n ϭ 17 cells). D: secretion rate, estimated from the product of mean quantal charge and event frequency, increased during aglycemia (Student's t-test, **P Ͻ 0.01, n ϭ 17 cells). E: exemplar trace from a cell that failed to respond to aglycemia but that displayed a strong catecholamine secretory response to high K ϩ . Data were compared with a two-way Student's t-test (**P Ͻ 0.01, ***P Ͻ 0.001, n ϭ 17 cells).
M) was used. Nifedipine abolished the aglycemia-evoked secretion from neonatal AMC; however, recovery after washout of nifedipine was poor (Fig. 6C ). These data indicate that the aglycemia-evoked catecholamine secretion requires the influx of extracellular Ca 2ϩ through L-type VGCCs (Fig. 6D) . It was recently proposed that hypoxia-evoked catecholamine secretion in neonatal AMCs required activation of T-type VGCCs (35); however, this idea remains controversial (50) . In the present study, 50 M Ni 2ϩ , a concentration that blocks T-type, but not L-type, Ca 2ϩ currents in neonatal AMCs (35) , reversibly inhibited aglycemia-evoked catecholamine secretion (Fig. 6 , E and F; P Ͻ 0.05, n ϭ 4). Thus it appears that both L-type and T-type VGCCs are involved in the secretory response of neonatal AMCs to aglycemia.
Interactive effects of hypoxia and aglycemia on catecholamine secretion. Because hypoxia potentiated the aglycemiaevoked inhibition of the outward K ϩ current and vice versa (Fig. 3E) , we tested the hypothesis that aglycemia-evoked catecholamine secretion from neonatal AMCs is potentiated during hypoxia. In one experimental series where 12 cells were examined, though 75% (n ϭ 9/12) were hypoxia sensitive and ϳ58% (n ϭ 7/12) were aglycemia sensitive as indicated by the presence of a detectable increase in catecholamine secretion, all (100%) of these cells (n ϭ 12/12) were sensitive to the combined application of both stimuli. In fact, a few cells showed no detectable secretory response to either hypoxia or aglycemia when applied separately; however, application of both stimuli together resulted in a strong secretory response (Fig. 7A, bottom) . When data from the 12 cells were pooled to determine the stimulus-evoked increase in secretion rate (evoked minus basal), it was found that hypoxia alone increased catecholamine secretion by 200.3 Ϯ 65.3 fC/min (n ϭ 12), compared with 184.4 Ϯ 99.8 fC/min (n ϭ 12) for aglycemia alone (Fig. 7B) . By contrast, combined application of hypoxia and aglycemia increased catecholamine secretion by 561 Ϯ 145.0 fC/min, corresponding to an approximately threefold increase over that induced by either stimulus alone (P Ͻ 0.05, n ϭ 12 cells). Because there was no significant difference between the sum of the secretion rates due to aglycemia alone plus hypoxia alone (384.7 Ϯ 152.2 fC/min) and the rate elicited by combined application of hypoxia and aglycemia (561 Ϯ 145.0 fC/min) (P ϭ 0.34, n ϭ 12 cells), it appears that the interaction between aglycemia and hypoxia was additive under these experimental conditions.
Effects of aglycemia on intracellular [Ca 2ϩ ] in neonatal AMCs. We have previously shown that aglycemia caused an increase in [Ca 2ϩ ] i in immortalized AMCs derived from fetal rat adrenal medulla (44) . In the present study, we used Fura-2 spectrofluorimetry to compare the effects of aglycemia and hypoxia on [Ca 2ϩ ] i in neonatal AMCs. As illustrated in ] i in a given experiment. Cells were considered responsive to a particular stimulus if there was a Ͼ20 nM increase in [Ca 2ϩ ] i above basal levels. By this criterion, ϳ42% (n ϭ 183/440) of neonatal AMCs were responsive to aglycemia, ϳ41% (n ϭ 179/440) were responsive to hypoxia, and ϳ24% of cells (n ϭ 106/440) were responsive to both hypoxia and aglycemia. When data were pooled from all experiments, aglycemia caused an increase in mean [Ca 2ϩ ] i from a basal level of 73.05 Ϯ 2.9 nM to 94.5 Ϯ 5.4 nM (P Ͻ 0.01, n ϭ 14), whereas hypoxia caused an increase from 84.15 Ϯ 5.5 nM (basal) to 107.2 Ϯ 7.5 nM (P Ͻ 0.01, n ϭ 14).
DISCUSSION
In this study we present evidence for an intrinsic glucosensing mechanism in neonatal rat AMCs that appears complementary to the effects of other asphyxial stimuli, i.e., hypoxia and acid hypercapnia, in stimulating the critical catecholamine surge at birth. In particular, low glucose produced membrane depolarization and a dose-dependent increase in action potential frequency in at least a subpopulation of neonatal AMCs. Moreover, aglycemia caused inhibition of outward K ϩ current in these cells, an effect similar to that previously reported in related carotid body type I cells (18, 42) . Though the identity of the specific ion channels mediating membrane depolarization and the inhibition of outward K ϩ current remains to be elucidated, we obtained evidence that aglycemia activated a In these experiments, the same cells were exposed sequentially to 5 mM glucose (control), 3 mM glucose (hypoglycemia), and 0 mM glucose (aglycemia) as illustrated in A. A, top: cumulative catecholamine secretion corresponding to the cell below. Bottom: exemplar trace from a cell showing catecholamine secretion in response to both hypoglycemia and aglycemia. B: histogram of catecholamine secretory rate (in fC/min) following sequential exposures of chromaffin cells to 3 mM and 0 mM glucose. Secretion was significantly enhanced at lower glucose concentrations relative to normoglycemia (5 mM glucose) (ANOVA, *P Ͻ 0.05, ***P Ͻ 0.001, n ϭ 7 cells).
glibenclamide-sensitive K ATP current that blunted the full extent of outward current inhibition seen at depolarized membrane voltages. Activation of this K ATP current also occurs when both neonatal and fetal rat AMCs are exposed to hypoxia (4, 59) , and its activation during aglycemia has previously been shown to limit the rise in intracellular Ca 2ϩ in an immortalized chromaffin cell line derived from fetal rat adrenal medulla (44) . It would appear that, during hypoxia and aglycemia, activation of the K ATP current serves a protective role in limiting cell excitability and/or the rise in intracellular Ca 2ϩ under conditions of low ATP production. Though we also obtained evidence for at least additive interactions between hypoglycemia and hypoxia leading to enhanced secretion when applied together, the final effect was likely blunted by the convergence of these stimuli on the activation of K ATP channels.
Though the ionic mechanism underlying the hypoglycemiainduced membrane depolarization in neonatal AMCs is currently unknown, a variety of ionic mechanisms have been proposed for glucosensing in other cells. In the developmentally related carotid body type I cells, hypoglycemia opens a nonselective cation channel thought to be a member of the canonical transient receptor potential (TRPC) channel family (18) . It is plausible that a similar mechanism may operate in neonatal AMCs, given that fetal-derived AMCs express a variety of TRPC channels (our unpublished microarray data). Paradoxically, K ATP channel closure has been proposed to mediate hypoglycemia-induced glucagon release in pancreatic ␣-cells (22) , whereas the coupling of the sulfonylurea receptor (SUR1) subunit of the K ATP channel to the melastatin TRP channel TRPM4 appears to confer glucose-sensitivity in brain astrocytes (8) . In other cases, the increase in membrane excitability during hypoglycemia has been attributable to the closure of CFTR chloride channels in arcuate nucleus neurons (16) , and either two-pore-domain K ϩ , inward rectifying K ir , or small-conductance Ca 2ϩ -activated K ϩ (SK) channels in orexin neurons (5, 25) .
In this study we found that 30 -40% of neonatal AMCs were sensitive to aglycemia, which is similar to previous reports on the proportion of hypoxia-sensitive (17, 58) and hypercapniasensitive populations (41) . The possibility that the effects of aglycemia are attributable simply to mitochondrial inhibition seems unlikely for several reasons. First, the observation that the combined action of aglycemia and hypoxia on secretion was additive in the present study suggests that the two stimuli act via different signaling pathways. Second, we previously showed that mitochondrial inhibition at complex I was involved in the hypoxia-sensing pathway in these cells because the complex I inhibitor rotenone was found to mimic and occlude the effects of hypoxia (57) . Third, in the present study, low glucose sensitivity could be unmasked in unresponsive cells or strengthened in responsive cells during coincubation A, top: trace of cumulative secretion corresponding to the cell below. Bottom: exemplar trace of a single cell that failed to respond to hypoxia or aglycemia applied separately but that produced a strong secretory response to the simultaneous application of both stimuli. B: in a population of cells, both hypoxia and aglycemia increased catecholamine secretion; however, the simultaneous application of both stimuli significantly potentiated catecholamine secretion (ANOVA; *P Ͻ 0.05, n ϭ 12).
with the K ATP channel blocker glibenclamide, implying that the effect of metabolic inhibition of ATP production was mainly inhibitory. Thus it appears that low glucose activates two competing pathways: 1) an excitatory pathway favoring membrane depolarization and increased excitability and 2) an inhibitory one favoring membrane hyperpolarization, mediated via the opening of K ATP channels. The relative strengths of these two pathways appear to be the major determinant as to whether a given cell is glucose sensitive or not.
The robust secretory response from neonatal AMCs exposed to low glucose was characterized by an increase in the frequency of quantal events and an increase in mean quantal charge. By contrast, hypoxia is known to increase the frequency of single quantal events, whereas hypercapnia increases mean quantal size in neonatal AMCs (17, 41) . It is unclear why different stimuli would evoke different patterns of secretion in neonatal AMCs, though the observed increase in action potential frequency during aglycemia correlates well with the increase in quantal event frequency (64) . It is plausible that activation of different classes of VGCCs, coupled with their spatial distribution in the plasma membrane, may activate different pools of dense-core vesicles, thereby regulating quantal size or frequency. In addition, the distribution of ion channel(s) involved in these responses to asphyxial stimuli may also play a key role in modifying secretion. For instance, hypercapnia activates a nonselective cation channel in neonatal AMCs and influx of Ca 2ϩ through this channel may modulate intracellular Ca 2ϩ signaling and modify secretion (41) . In the present study, the aglycemia-evoked catecholamine secretion required influx of extracellular Ca 2ϩ through both L-type and T-type VGCCs, on the basis of its sensitivity to the blockers nifedipine as well as both high (2 mM) and low (50 M) concentrations of Ni 2ϩ . The requirement for L-type VGCCs is consistent with the secretory response of these cells to hypoxia and hypercapnia (41, 58) . However, although blockade of T-type VGCC with low concentrations Ni 2ϩ abolished hypoxia-evoked secretion from neonatal AMCs in fresh adrenal slices (35) , the T-type VGCC blocker mibefradil (10 M) failed to affect hypoxia-evoked secretion from neonatal AMCs in dissociated cell culture (50) .
Polymodal chemosensing and interactions among asphyxial stimuli. In addition to a population of glucose-sensitive AMCs, a significant proportion of AMCs failed to respond to aglycemia alone with increased catecholamine secretion. In such cells the low glucose stimulatory pathway could have been lacking or functioning at a low level, or conceivably they expressed relatively high levels of K ATP channels which rendered them glucose insensitive, by favoring membrane hyperpolarization during hypoglycemia (44) . Nevertheless, it was plausible that such cells could still participate in the final secretory response when the action of low glucose was combined with that of another stimulus such as hypoxia. Evidence for such stimulus interaction was obtained in several cases where combined application of aglycemia and hypoxia produced a greater secretory response than that elicited by either stimulus alone. Also, in electrophysiological studies we found that, for a given glucose concentration, the degree of outward K ϩ current inhibition was enhanced as PO 2 was lowered and vice versa. Such interactions may be relevant to catecholamine secretion from AMCs in vivo where arterial PO 2 (90 mmHg) is much lower than atmospheric (150 mmHg). Moreover, because most mammals develop in a constitutively hypoxic environment in utero (PO 2 ϳ30 mmHg) (45) and may experience bouts of hypoxia attributable to apnoeic episodes at birth, it would appear that the effects of the combined stimuli are more relevant physiologically. Indeed, the actual secretory response is likely to be further potentiated when interactions with other metabolic factors that contribute to asphyxial stressors at birth, e.g., acid hypercapnia, are included. Consistent with this, in the present study we found subpopulations of neonatal AMCs that were sensitive to three metabolic stimuli, i.e., aglycemia, hypoxia, and hypercapnia; together these stimuli would be expected to elicit a robust catecholamine secretion compared with that produced by any one stimulus alone.
Clinical significance. Our study is relevant to the counterregulatory hormonal changes that occur in response to hypoglycemia in perinatal mammals and provides a mechanistic understanding at the level of the secretory functions of the adrenal medulla. It is well known that maternal hypoglycemia or occlusion of the umbilical artery, which occurs occasionally during development, produces hypoglycemia in the fetus (12) , leading to a surge of catecholamines that in turn causes an increase in circulating glucagon and depletion of liver glycogen (19, 24, 43) . Critically, fetal adrenergic receptor blockade increases insulin secretion and reduces circulating glucose, suggesting that catecholamines play a role in glucose homeostasis in the steady state in utero (33) . In human pregnancies complicated by maternal diabetes, standard practice involves tight glycemic control to avoid the severe morbidities and mortalities associated with hyperglycemia in utero (55) . Implementation of these practices has increased bouts of maternal hypoglycemia, leading to fetal hypoglycemia and hypoinsulinemia (47) , which in turn produces changes in fetal heart rate and movement (2, 10, 28, 32, 52) , as well as increased surfactant in the amniotic fluid (62) . The implication of these studies is that fetal AMCs are capable of responding to hypoglycemia with inappropriately timed catecholamine secretion. On the other hand, the transport of wastes and nutrients across the umbilical cord is of necessity occluded at birth, and blood glucose decreases to a nadir of about 2-3 mM during the first 2 h of life before stabilizing at a higher level (26, 30, 39, 51, 54) . Tissue concentrations of glucose are likely to be much lower at this time given that, during hypoglycemia, interstitial glucose can decrease to ϳ34% of plasma glucose (37) . This hypoglycemia occurs in concert with hypoxia and acid hypercapnia, and we propose that the combined, direct actions of these stimuli on neonatal AMCs provide the physiological trigger for the vital catecholamine surge that prepares the newborn for extrauterine life. In humans, maternal hyperglycemia at birth produces neonatal hyperinsulinemia and is inversely correlated to the degree of hypoglycemia in the neonate an hour after birth (51) . Moreover, premature infants, newborns of diabetic mothers, and small-for-gestational age neonates are at increased risk of hypoglycemia (61) . Interestingly, the hypoglycemia-evoked counterregulatory surge in catecholamines and glucagon is absent in infants of diabetic mothers (3, 53) . Given that dysfunction of perinatal glucose homeostasis increases the risk of perinatal morbidity and mortality, a better understanding of the glucosensing mechanisms in these cells would aid in the design of appropriate therapeutic interventions. 
